Revenue Summary of Sonendo, Inc.

Sonendo, Inc.'s latest annual revenue in 2023 was 43.86 Million USD , up 5.3% from previous year.
Sonendo, Inc.'s latest quarterly revenue in 2024 Q2 was 8.31 Million USD , up 17.98% from previous quarter.
Sonendo, Inc. reported a annual revenue of 41.65 Million USD in annual revenue 2022, up 25.48% from previous year.
Sonendo, Inc. reported a annual revenue of 33.19 Million USD in annual revenue 2021, up 42.17% from previous year.
Sonendo, Inc. reported a quarterly revenue of 8.31 Million USD for 2024 Q2, up 17.98% from previous quarter.
Sonendo, Inc. reported a quarterly revenue of 10.72 Million USD for 2023 Q1, down -12.31% from previous quarter.

Annual Revenue Chart of Sonendo, Inc. (2023 - 2019)

Name	Revenue	Revenue Difference
Abbott Laboratories	40.1 Billion USD	99.891%
Allurion Technologies Inc.	53.46 Million USD	17.959%
Artivion, Inc.	354 Million USD	87.609%
Avanos Medical, Inc.	673.3 Million USD	93.485%
Butterfly Network, Inc.	65.9 Million USD	33.437%
Butterfly Network, Inc.	65.9 Million USD	33.437%
Bio-Rad Laboratories, Inc.	2.67 Billion USD	98.358%
Boston Scientific Corporation	14.24 Billion USD	99.692%
Perspective Therapeutics, Inc.	7.1 Million USD	-517.469%
CONMED Corporation	1.24 Billion USD	96.465%
Edwards Lifesciences Corporation	6 Billion USD	99.27%
Paragon 28, Inc.	216.38 Million USD	79.729%
Glaukos Corporation	314.71 Million USD	86.062%
Globus Medical, Inc.	1.56 Billion USD	97.203%
Inspire Medical Systems, Inc.	624.79 Million USD	92.979%
Integer Holdings Corporation	1.59 Billion USD	97.253%
Medtronic plc	32.36 Billion USD	99.864%
Nevro Corp.	425.17 Million USD	89.683%
Owlet, Inc.	54.01 Million USD	18.784%
Penumbra, Inc.	1.05 Billion USD	95.856%
Vicarious Surgical Inc.	- USD	-Infinity%
Smith & Nephew plc	5.54 Billion USD	99.209%
STERIS plc	5.13 Billion USD	99.146%
Stryker Corporation	20.49 Billion USD	99.786%
Vapotherm, Inc.	68.66 Million USD	36.121%
Zimmer Biomet Holdings, Inc.	7.39 Billion USD	99.407%